Louis J. Bont MD, PhD

Louis Bont, MD, Ph.D., is a Pediatric Infectious Diseases and Immunology Specialist at the Wilhelmina Children’s Hospital of the University Medical Center Utrecht. He is the founding chairman of ReSViNET, an international respiratory syncytial virus (RSV) research consortium. His specific research interest is RSV pathogenesis and the burden of disease. His work focuses on unraveling the role of neutrophil granulocytes, RSV-related mortality, and long-term airway disease following RSV infection.

Dr. Bont is chairman of the Institutional Review Board at the University Medical Center Utrecht, the Netherlands. He is an advisor for the World Health Organization, the Bill and Melinda Gates Foundation, the National Institute of Health of the United States, the European Center of Disease Control, and several pharmaceutical companies. He founded the Training of Upcoming Leaders in Pediatric Science (TULIPS), a successful career training network for clinician-scientists in the field of Child Health. Louis Bont is an active member of ESPID and ESCMID.